CVS Health (CVS) Tops Q1 EPS by 36c; raises guidance
Get Alerts CVS Hot Sheet
Price: $94.30 -0.47%
Revenue Growth %: +1.8%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
OMID, BCML, CZNC, More
Revenue Growth %: +1.8%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.57, $0.36 better than the analyst estimate of $2.21. Revenue for the quarter came in at $100.4 billion versus the consensus estimate of $95.02 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.30-$7.50, versus the consensus of $7.16.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- US Treasury: 'Authorizing Wind Down Activities...the Offloading of Cargo Involving Certain Persons or Vessels Blocked on October 21, 2026'
- Moody's Corp. (MCO) Misses Q3 EPS by 11c; offers guidance
- Plumas Bancorp (PLBC) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share